Skip to main content
. 2019 Nov 4;51(12):644–656. doi: 10.1152/physiolgenomics.00077.2019

Table 4.

Serum concentration of selected proteins and clinical biochemical indices of study subjects

Healthy Group
(n = 103)
HF Group
(n = 75)
ACS Group
(n = 93)
CCHD Group
(n = 108)
TC, mmol/L 4.71 ± 0.49 3.77 ± 0.98 4.66 ± 1.48 4.34 ± 1.21
TG, mmol/L 1.05 ± 0.36 1.21 ± 0.62 1.83 ± 1.28 1.64 ± 0.98
HDL, mmol/L 1.30 ± 0.19 0.99 ± 0.31 0.96 ± 0.26 1.00 ± 0.30
LDL, mmol/L 2.78 ± 0.39 2.35 ± 0.59 2.94 ± 1.11 2.71 ± 0.97
AopA-1, g/L 1.37 ± 0.31 1.04 ± 0.23 1.09 ± 0.23 1.13 ± 0.27
ApoB, g/L 0.82 ± 0.16 0.80 ± 0.25 0.90 ± 0.29 0.87 ± 0.30
LPa, g/L 0.11 (0.00,0.60) 0.26 (0.02,1.22)* 0.22 (0.01,1.22) 0.22 (0.00,1.12)
HCY, μmol/L 19.70 (8.60,184.00) 22.60 (9.10,36.30)* 17.15 (7.00,35.80) 19.85 (0.00,38.50)
Myo, ng/mL 26.62 (15.54,81.37) 56.30 (0.00,576.39) 56.36 (25.74,1000.00) 50.71 (17.93,819.04)
CTnI, ng/mL 0.00 (0.00,0.04) 0.07 (0.00,6.39) 3.79 (0.00,49.00) 0.02 (0.00,49.00)
CK, U/L 77 (6,912) 84 (25,1243) 168 (13,5573) 88 (2.88,2680)*
CK-MBm, ng/mL 0.01 (0.00,1.58) 1.61 (0.00,12.00) 2.18 (0.00,246.00) 1.04 (0.00,109.62)
CK-MB, U/L 11.00 (1.00,143.00) 12.50 (4.00,35.00) 20.50 (4.00,462.00) 14.00 (5.00,166.00)
CRP, mg/L 0.65 (0.01,257.00) 11.90 (0.09,120.70) 5.03 (0.20,178.70) 1.90 (0.08,156.10)
LDH, U/L 190 (80,365) 240.50 (0,790) 265 (127,1111) 168 (77,1181)
AST, U/L 22 (16,105) 30 (9,242) 35.5 (10,343) 21 (10,1104)
SPP1, ng/mL 1.50 (0.18,9.08) 19.17 (0.12,70.88) 22.87 (0.55,120.20) 4.90 (0.23,226.99)
MMP7, ng/mL 5.06 (0.32,19.85) 2.06 (0.32,7.16) 5.69 (0.32,15.24) 2.06 (0.32.104.00)
TREM1, pg/mL 104.47 (63.69,324.78) 129.88 (86.42,351.10) 119.89 (55.16,920.45) 115.07 (56.34,9888.96)
S100A9, pg/mL 1086.08 (716.48,1679.37) 1071.11 (504.91,4381.86) 1045.59 (590.85,3103.03) 1086.13 (590.85,28213.91)
CD36, ng/mL 1902.45 ± 962.81 2037.25 ± 1445.03 4065.74 ± 2845.85 3382.15 ± 1820.44
TM4SF19, pg/mL 56.19 (43.37,216.89) 80.50 (46.79,169.68) 89.61 (43.50,7660.00) 116.70 (42.28,375.93)
FABP5, ng/mL 1.20 ± 0.50 1.06 ± 0.33 1.23 ± 0.68 1.00 ± 0.58
ATP6V0D2, ng/mL 11.32 ± 1.08 14.45 ± 1.10* 13.44 ± 1.68 13.00 ± 2.92*
CXCR4, pg/mL 178.26 (75.41,599.89) 164.62 (89.71,882.16) 184.72 (52.30,845.48) 205.41 (40.34,3623.1)
CHI3L1, ng/mL 32.94 ± 8.44 50.81 ± 14.35* 67.48 ± 28.53 52.80 ± 27.93
MYOCD, nmol/mL 4.94 ± 0.38 6.01 ± 1.35 4.17 ± 0.57 4.55 ± 0.39
SCARA3, ng/mL 0.58 (0.41,2.15) 0.81 (0.47,1.79) 0.67 (0.001,15.75) 1.05 (0.34,5.50)
FIBIN, ng/mL 8.33 (6.43,25.59) 9.49 (6.14,15.46) 10.99 (5.64,2030.08) 10.28 (6.09,26.10)
TRIM36, ng/mL 1.78 ± 0.37 1.61 ± 0.28 1.87 ± 0.84 1.88 ± 0.36
ACADL, ng/mL 18.60 (11.09,56.06) 13.30 (10.36,20.54) 17.06 (8.52,35.10) 13.66 (6.08,142.10)
IGFBPL1, ng/mL 1.69 (0.70,2.94) 2.75 (0.92,13.32) 2.06 (0.64,11.47) 1.48 (0.70,7.38)
MYH11, pg/mL 341.57 (239.47,1786.18) 666.46 (481.04,1559.76) 617.55 (305.71,6767.05) 823.25 (288.47,8571.14)
TTLL7, ng/mL 0.95 (0.45,4.00) 1.24 (0.42,2.52) 1.55 (0.45,3.69) 1.41 (0.48,3.76)
BDNF, pg/mL 4308.07 ± 903.54 2939.72 ± 955.59* 3066.50 ± 1260.44 3193.47 ± 1091.37
MYLK, ng/mL 55.55 (4.86,289.35) 66.17 (28.79,230.54) 70.94 (18.34,402.53) 76.67 (14.25,314.84)
TC, mmol/L 4.71 ± 0.49 3.77 ± 0.98 4.66 ± 1.48 4.34 ± 1.21
TG, mmol/L 1.05 ± 0.36 1.21 ± 0.62 1.83 ± 1.28 1.64 ± 0.98
HDL, mmol/L 1.30 ± 0.19 0.99 ± 0.31 0.96 ± 0.26 1.00 ± 0.30
LDL, mmol/L 2.78 ± 0.39 2.35 ± 0.59 2.94 ± 1.11 2.71 ± 0.97
AopA-1, g/L 1.37 ± 0.31 1.04 ± 0.23 1.09 ± 0.23 1.13 ± 0.27
ApoB, g/L 0.82 ± 0.16 0.80 ± 0.25 0.90 ± 0.29 0.87 ± 0.30
LPa, g/L 0.11 (0.00,0.60) 0.26 (0.02,1.22)* 0.22 (0.01,1.22) 0.22 (0.00,1.12)
HCY, μmol/L 19.70 (8.60,184.00) 22.60 (9.10,36.30)* 17.15 (7.00,35.80) 19.85 (0.00,38.50)
Myo, ng/mL 26.62 (15.54,81.37) 56.30 (0.00,576.39) 56.36 (25.74,1000.00) 50.71 (17.93,819.04)
CTnI, ng/mL 0.00 (0.00,0.04) 0.07 (0.00,6.39) 3.79 (0.00,49.00) 0.02 (0.00,49.00)
CK, U/L 77 (6,912) 84 (25,1243) 168 (13,5573) 88 (2.88,2680)*
CK-MBm, ng/mL 0.01 (0.00,1.58) 1.61 (0.00,12.00) 2.18 (0.00,246.00) 1.04 (0.00,109.62)
CK-MB, U/L 11.00 (1.00,143.00) 12.50 (4.00,35.00) 20.50 (4.00,462.00) 14.00 (5.00,166.00)
CRP, mg/L 0.65 (0.01,257.00) 11.90 (0.09,120.70) 5.03 (0.20,178.70) 1.90 (0.08,156.10)
LDH, U/L 190 (80,365) 240.50 (0,790) 265 (127,1111) 168 (77,1181)
AST, U/L 22 (16,105) 30 (9,242) 35.5 (10,343) 21 (10,1104)
SPP1, ng/mL 1.50 (0.18,9.08) 19.17 (0.12,70.88) 22.87 (0.55,120.20) 4.90 (0.23,226.99)
MMP7, ng/mL 5.06 (0.32,19.85) 2.06 (0.32,7.16) 5.69 (0.32,15.24) 2.06 (0.32.104.00)
TREM1, pg/mL 104.47 (63.69,324.78) 129.88 (86.42,351.10) 119.89 (55.16,920.45) 115.07 (56.34,9888.96)
S100A9, pg/mL 1086.08 (716.48,1679.37) 1071.11 (504.91,4381.86) 1045.59 (590.85,3103.03) 1086.13 (590.85,28213.91)
CD36, ng/mL 1902.45 ± 962.81 2037.25 ± 1445.03 4065.74 ± 2845.85 3382.15 ± 1820.44
TM4SF19, pg/mL 56.19 (43.37,216.89) 80.50 (46.79,169.68) 89.61 (43.50,7660.00) 116.70 (42.28,375.93)
FABP5, ng/mL 1.20 ± 0.50 1.06 ± 0.33 1.23 ± 0.68 1.00 ± 0.58
ATP6V0D2, ng/mL 11.32 ± 1.08 14.45 ± 1.10* 13.44 ± 1.68 13.00 ± 2.92*
CXCR4, pg/mL 178.26 (75.41,599.89) 164.62 (89.71,882.16) 184.72 (52.30,845.48) 205.41 (40.34,3623.1)
CHI3L1, ng/mL 32.94 ± 8.44 50.81 ± 14.35* 67.48 ± 28.53 52.80 ± 27.93
MYOCD, nmol/mL 4.94 ± 0.38 6.01 ± 1.35 4.17 ± 0.57 4.55 ± 0.39
SCARA3, ng/mL 0.58 (0.41,2.15) 0.81 (0.47,1.79) 0.67 (0.001,15.75) 1.05 (0.34,5.50)
FIBIN, ng/mL 8.33 (6.43,25.59) 9.49 (6.14,15.46) 10.99 (5.64,2030.08) 10.28 (6.09,26.10)
TRIM36, ng/mL 1.78 ± 0.37 1.61 ± 0.28 1.87 ± 0.84 1.88 ± 0.36
ACADL, ng/mL 18.60 (11.09,56.06) 13.30 (10.36,20.54) 17.06 (8.52,35.10) 13.66 (6.08,142.10)
IGFBPL1, ng/mL 1.69 (0.70,2.94) 2.75 (0.92,13.32) 2.06 (0.64,11.47) 1.48 (0.70,7.38)
MYH11, pg/mL 341.57 (239.47,1786.18) 666.46 (481.04,1559.76) 617.55 (305.71,6767.05) 823.25 (288.47,8571.14)
TTLL7, ng/mL 0.95 (0.45,4.00) 1.24 (0.42,2.52) 1.55 (0.45,3.69) 1.41 (0.48,3.76)
BDNF, pg/mL 4308.07 ± 903.54 2939.72 ± 955.59* 3066.50 ± 1260.44 3193.47 ± 1091.37
MYLK, ng/mL 55.55 (4.86,289.35) 66.17 (28.79,230.54) 70.94 (18.34,402.53) 76.67 (14.25,314.84)

Data are presented as means ± SD or medians (interquartile range) unless otherwise indicated. ACS, acute coronary syndrome; CCHD, chronic coronary heart disease; HF, heart failure. Compared with healthy group:

*

P < 0.05;

P < 0.01;

P < 0.001.